Programming of the hypothalamo-pituitary-adrenal axis and the fetal origins of adult disease hypothesis

被引:118
作者
Clark, PM [1 ]
机构
[1] Univ Southampton, Southampton Gen Hosp, MRC, Environm Epidemiol Unit, Southampton SO16 6YD, Hants, England
关键词
fetal growth; blood pressure; glucose tolerance; programming; HPA axis;
D O I
10.1007/PL00014289
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
There is now a large body of evidence to support the hypothesis that events in fetal life permanently alter the structure or function of an individual, programming later adult disease. Reduced birth weight is associated with higher blood pressure in childhood and adult life, and thinness at birth with glucose intolerance and non-insulin dependent diabetes mellitus. Programming of the hypothalamo-pituitary-adrenal (HPA) axis is an attractive hypothesis linking fetal experience and later disease, as an excess of glucocorticoids may be associated with hypertension and glucose intolerance. Moreover, animal data support this hypothesis. Exposing fetal rats to glucocorticoid reduces birth weight and leads to raised blood pressure, as well as to alterations in the HPA axis. Data on the long-term effects of exposure to glucocorticoids in human subjects are limited. Recently, however, reduced size at birth was found to be associated with higher fasting 9 a.m. plasma cortisol concentrations in adults. Raised plasma cortisol concentrations were, in turn, associated with higher blood pressure, and inversely related to measures of glucose tolerance.
引用
收藏
页码:S7 / S10
页数:4
相关论文
共 22 条
[1]  
BARKER DJP, 1986, LANCET, V1, P1077
[2]   GLUCOCORTICOID EXPOSURE INUTERO - NEW MODEL FOR ADULT HYPERTENSION [J].
BENEDIKTSSON, R ;
LINDSAY, RS ;
NOBLE, J ;
SECKL, JR ;
EDWARDS, CRW .
LANCET, 1993, 341 (8841) :339-341
[3]  
Benediktsson R, 1995, J ENDOCRINOL, V144, P161
[4]  
CARTER J, 1984, LOW BIRTHWEIGHT MED, P191
[5]   Size at birth and adrenocortical function in childhood [J].
Clark, PM ;
Hindmarsh, PC ;
Shiell, AW ;
Law, CM ;
Honour, JW ;
Barker, DJP .
CLINICAL ENDOCRINOLOGY, 1996, 45 (06) :721-726
[6]   ANTENATAL CORTICOSTEROID-THERAPY - A METAANALYSIS OF THE RANDOMIZED TRIALS, 1972 TO 1994 [J].
CROWLEY, PA .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1995, 173 (01) :322-335
[7]  
ECONOMIDES D L, 1988, Fetal Therapy, V3, P158
[8]   ELEVATED LEVELS OF UMBILICAL-CORD PLASMA CORTICOTROPIN-RELEASING HORMONE IN GROWTH-RETARDED FETUSES [J].
GOLAND, RS ;
JOZAK, S ;
WARREN, WB ;
CONWELL, IM ;
STARK, RI ;
TROPPER, PJ .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1993, 77 (05) :1174-1179
[9]  
HACK M, 1980, EPIDEMIOL PREV PED A, V93
[10]   FETAL AND INFANT GROWTH AND IMPAIRED GLUCOSE-TOLERANCE AT AGE 64 [J].
HALES, CN ;
BARKER, DJP ;
CLARK, PMS ;
COX, LJ ;
FALL, C ;
OSMOND, C ;
WINTER, PD .
BMJ-BRITISH MEDICAL JOURNAL, 1991, 303 (6809) :1019-1022